| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |